(Q50483769)

English

The influence of methylene blue light treatment and methylene blue removal filter on fibrinogen activity states and fibrin polymerisation indices.

scientific article published in August 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/16029868

The influence of methylene blue light treatment and methylene blue removal filter on fibrinogen activity states and fibrin polymerisation indices. (English)

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/16029868

author name string

François Depasse

1

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/16029868

Luc Sensebé

2

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/16029868

Jerard Seghatchian

3

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/16029868

Georges Andreu

4

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/16029868

Meyer-Michel Samama

5

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/16029868

publication date

1 August 2005

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/16029868

Transfusion and Apheresis Science

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/16029868

33

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/16029868

1

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/16029868

63-69

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/16029868

Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.02.002

7 January 2021

Virus inactivation in blood components by photoactive phenothiazine dyes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.02.002

7 January 2021

The effect of methylene blue phototreatment on plasma proteins and in vitro coagulation capability of single-donor fresh-frozen plasma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.02.002

7 January 2021

Coagulation factor content of cryoprecipitate prepared from methylene blue plus light virus-inactivated plasma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.02.002

7 January 2021

Transfusing methylene blue-photoinactivated plasma instead of FFP is associated with an increased demand for plasma and cryoprecipitate.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.02.002

7 January 2021

What's happening? The quality of methylene blue treated FFP and cryo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.02.002

7 January 2021

Changes in functional activities of plasma fibrinogen after treatment with methylene blue and red light

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.02.002

7 January 2021

The effect of methylene blue photoinactivation and methylene blue removal on the quality of fresh-frozen plasma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.02.002

7 January 2021

Current strategies for the provision of safer plasma and its derivatives: an update

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.02.002

7 January 2021

Methylene blue-treated fresh-frozen plasma: what is its contribution to blood safety?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.02.002

7 January 2021

Persistence of HTLV-I in blood components after leukocyte depletion

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.02.002

7 January 2021

Proteomics of methylene blue photo-treated plasma before and after removal of the dye by an absorbent filter.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.02.002

7 January 2021

Role of methylene blue-treated or fresh-frozen plasma in the response to plasma exchange in patients with thrombotic thrombocytopenic purpura.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.02.002

7 January 2021

Clinical tolerance of methylene blue virus-inactivated plasma. A randomized crossover trial in 12 healthy human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.02.002

7 January 2021

Residual cell content in plasma produced by three centrifugal apheresis procedures

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.02.002

7 January 2021

The quality of clinical FFP, cryoprecipitate and cryosupernatant derived from single donor apheresis procedures and random donations collected in a BAT system: assessment of the activity states of FVIII, contact activation, microvesicle content and

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.02.002

7 January 2021

Identifiers

10.1016/J.TRANSCI.2005.02.002

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/16029868

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/16029868

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50483769&oldid=1367166988"